Health House International Ltd (hhi) Logo

Health House International Ltd (HHI)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

HHI Chart

HHI's Principal Activity is the provision of a cloud-based video e-learning software platform (Learning Management System or LMS) and a brand technology agency (Consulting Services); Realising assets, winding down operations of its former businesses and seeking new investment opportunities.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +3001.51%

Size

Market Capitalisation
ASX Rank 2,092 of 2,297
Sector Rank

Key Information

Shares Issued
Sector Healthcare
Similar Companies -
EPS -$0.001
DPS $0.00
NTA per share $0.00

Broker Consensus

HHI is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Health House International Limited (HHI, formerly VPCL Limited) operates a pharmaceutical distribution business with a focus on medicinal cannabis products relies on the company and its subsidiaries obtaining the necessary registrations and authorities under relevant laws.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Perth WA 6000
Website www.healthhouse.com.au
Registry Link Market Services
Auditor BDO Audit Pty Ltd
Date Listed 28 Jul 2011

Upcoming Calendar (Forecasted)

Date Event
30/08/2021 Report (Prelim)
30/09/2021 Report (Annual)
28/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Henrik Sprengel Executive Director May 2021 Director Bio icon

Dr Henrik Sprengel

Executive Director

Dr Sprengel is co-founder of both CanPharma and Kalapa Clinic where he has gained experience in the field of medicinal cannabis. Before founding CanPharma, he was CEO of the company builder Grupo HS3, which launched several international projects across a number of industries, with a focus on internet and technology. Henrik started his career as a lawyer at Clifford Chance; he later held several international senior management positions in global media company Bertelsmann, and as country manager for Spain and Mexico for a German media and tech company.

Mr David Attwood Chief Executive Officer May 2021
Hon Michael Rann Non-Executive Director Mar 2021 Director Bio icon

Hon Michael Rann

Non-Executive Director

The Hon Rann is former Premier of South Australia, is currently a resident of London. He holds Australian, UK and New Zealand citizenships. Following 26 years in Australian politics, he served as Australian High Commissioner to the UK and then as Ambassador to Italy. Mr Rann is Chairman of the UK registered charity The Power of Nutrition and is a member of the UK, US and Global boards of the London headquartered The Climate Group. He is CEO of his UK based business consultancy Rann Strategy Group.

Mr Timothy (Tim) Ryan Slate Company Secretary Mar 2021
Mr David Colin Wheeler Executive Chairman,Executive Director Apr 2020 Director Bio icon

Mr David Colin Wheeler

Executive Chairman,Executive Director

Mr Wheeler has more than 30 years of senior executive management, directorships and corporate advisory experience in both Australia and foreign countries and regions including the USA, UK, Europe and Asia. Mr Wheeler is a foundation director and partner of Pathways Corporate. a Corporate Advisory firm. David serves on both public and private boards and currently holds a number of directorships and advisory positions in Australian ASX listed companies. He is Director of Thred Limited, Avira Resources Limited, Blaze International Limited. Protean Waver Energy Limited, Eneabba Gas Limited, Ragnar Minerals Limited, Tyranna Resources Limited. Syntonic Limited and VPCL Limited.

Mr Christopher (Chris) Lee Mews Non-Executive Director Jul 2018 Director Bio icon

Mr Christopher (Chris) Lee Mews

Non-Executive Director

Mr Mews has been in financial services for over 20 years and is experienced in the financial operation, governance and compliance of Managed Investment Schemes, ASX listed companies and unlisted companies. Mr Mews has held senior positions in finance, corporate secretarial and compliance. In these roles he has been a member of senior management and due diligence and acquisition of Managed Investment Schemes and participated in various capital raisings for Managed Investment Schemes, ASX listed companies and unlisted companies. He is Director of Auscann Group Holdings Ltd.

Director Transactions

HHI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/03/21 David Wheeler Issued 20,000 $0.20 $4,000 Issue of securities
19/03/21 David Wheeler Buy +4,965,929 $0.20 $993,186 As advised by the company
19/03/21 David Wheeler Buy +1 $0.00 $0 As advised by the company
19/03/21 Leanne Graham Transfer 13,333 $0.004 $53 Off-market transfer
19/03/21 Leanne Graham Transfer 13,333 $0.004 $53 Off-market transfer

Director Interests

The current holdings of HHI directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Michael Rann 19/03/2021 226,085 N/A N/A N/A
David Wheeler 19/03/2021 1 4,965,929 N/A N/A
Christopher (Chris) Mews 04/02/2021 N/A 12,500 N/A N/A
Henrik Sprengel N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Sep 28, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
The Trust Company (Australia) Limited 100,000,000 8.84%
Chameleon Creative Pty Ltd 53,411,559 4.72%
Chameleon Creative Pty Ltd (I) 53,280,000 4.71%
Mr Russell John Francis 52,500,000 4.64%
Mr Johnathon Matthews 24,539,680 2.17%
The Investment C0 Pty Ltd 24,275,000 2.15%
Mr Mark Andrew Tkocz & Ms Susan Elizabeth Evans 15,000,000 1.33%
Mr Aslam Naveed Shafeek 14,260,000 1.26%
Gorra & Co Pty Ltd 13,500,000 1.19%
IBT Holdings Pty Ltd 13,000,000 1.15%
ABN Amro Clearing Sydney Nominees Pty Ltd 12,831,695 1.13%
Mr Vince Truda 12,720,000 1.12%
Combined Vision Pty Ltd 11,997,129 1.06%
Towns Corporation Pty Ltd 10,410,000 0.92%
Mulloway Pty Ltd 10,000,000 0.88%
TCH Holdings Pty Ltd 10,000,000 0.88%
Ms Jianmin Xiao 8,315,405 0.74%
BNZ Corporation Pty Ltd 8,204,806 0.73%
Mrs Carolyn Katz 8,000,000 0.71%
Vtech Holding Pty Ltd 7,721,000 0.68%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 37 38 73 516 705 1,369

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
The Trust Company (Australia) Limited 28/09/2020 100,000,000 8.84
Jason Peterson 15/04/2021 17,336,651 10.91

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
15-04-21 Jason Peterson 17,336,651 -- 10.91

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
16-04-21 Merchant Funds Management Pty Ltd 100,000,000 8.84 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
HHI Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.